This was from a post I didn't do last night, background info.
The aGVHD Expanded Access Program (EAP) seems to have started in 2008, so a decade ago is quite reasonable.
A while ago I posed the question what happens now to all the children who did not qualify for the trial now the EAP "trial" seemed to have finished, never did get an answer.
Last night I found the Mesoblast Policy on Expanded Access - Effective 10th February 2017, for all treatments, global.
Short answer, all good.
CBS in New York today - GvHD, page-7
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.010(1.09%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 90.5¢ | 94.0¢ | 89.5¢ | $4.970M | 5.436M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18877 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 6795 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |